Arsenic in Cancer Treatment: Challenges for Application of Realgar Nanoparticles (A Minireview)
2010
Arsenic in Cancer Treatment: Challenges for Application of Realgar Nanoparticles
Sample size: 16
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Baláž Peter, Sedlák Ján
Primary Institution: Slovak Academy of Sciences
Hypothesis
Can realgar nanoparticles improve the effectiveness of arsenic in cancer treatment?
Conclusion
Realgar nanoparticles show promise as a safe and effective treatment for acute promyelocytic leukemia.
Supporting Evidence
- Realgar nanoparticles have shown significant cytotoxic effects on cancer cells.
- Patients treated with realgar nanoparticles experienced complete remission in acute promyelocytic leukemia.
- Realgar's low solubility limits its effectiveness, but nanoparticles improve bioavailability.
- Combination therapies using realgar and other agents may enhance treatment outcomes.
Takeaway
This study looks at how tiny particles of realgar, a form of arsenic, can help treat cancer better and with fewer side effects.
Methodology
The review discusses various studies on the use of realgar nanoparticles in cancer treatment, focusing on their effects on different cancer cell lines and their bioavailability.
Limitations
The review primarily focuses on in vitro and in vivo studies without extensive clinical trial data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website